MXCT vs WMT · rev $38.6M vs P/E 42, rev $713.16B
MaxCyte Inc (MXCT) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported WMT revenue for 2026-01-31 was $713.16B. Net income was $21.89B. Revenue was up 4.7% from 2025-01-31 to 2026-01-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
MXCT currently screens at market cap $124.3M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the MXCT and WMT stock pages for the full models.
Not investment advice.